Join our email list to stay up to date on the latest Amyloidosis news.

2019 was a year of great accomplishments for the Amyloidosis Research Consortium (ARC), and we are grateful to all of you who have so generously supported our efforts to accelerate the pace of development of drugs to treat and improve quality of life for amyloidosis patients. (more…)

*
*
*








*